TeraWulf Reports Preliminary Third Quarter 2025 Financial Results Strong year-over-year growth reflects strategic repositioning to HPC hosting and continued growth momentum GlobeNewswire October 28, 2025 EASTON, Md., Oct. 28, 2025 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today announced preliminary […]

(Other OTC:GAMI),(OTC US:GAMI),(NYSE:AAP),(NYSE:AN),(NYSE:AZO),(NYSE:DAN),(NYSE:DCI),(NASDAQ:DORM),(NASDAQ:GTX),(NASDAQ:GNTX),(NASDAQ:LKQ),(NASDAQ:MNRO),(NASDAQ:MPAA),(NYSE:MP),(NASDAQ:NNBR),(NASDAQ:ORLY),(NYSE:PAG),(NYSE:PHIN),(NYSE:SAH),(NYSE:SMP),(NasdaqGM:STRT),(NYSE:GPC),(NASDAQ:RUSHB), GREENWICH, Conn., Oct. 28, 2025 (GLOBE NEWSWIRE) — Gabelli Funds will host its 49th Annual Automotive Symposium on November 3rd and 4th, 2025 at the Encore at Wynn in Las Vegas, Nevada. This two-day symposium will feature presentations by senior management of leading automotive and trucking companies, with a lineup that allows

PMGC Holdings Inc.'s Subsidiary, AGA Precision Systems LLC, Completes Acquisition of Indarg Engineering, Inc. Expanding Aerospace and Defense Manufacturing Platform GlobeNewswire October 28, 2025 Strategic Acquisition Accelerates PMGC's U.S. Manufacturing Roll-Up, Expanding Footprint Across Aerospace and Industrial Supply Chains Acquisition Adds Profitable CNC Platform with Established Customer Relationships to drive earnings scalability and operational synergies

(NASDAQ:RXRX), Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 financial results on Wednesday, November 5, 2025, before the open of the financial markets. Recursion will

OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers GlobeNewswire October 28, 2025 First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — ModeX

ORYZON Strengthens Regulatory Strategy with the Appointment of Dr. Iman Barilero as Senior Advisor for Regulatory Affairs GlobeNewswire October 28, 2025 To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programs To bring deep expertise in CNS and immuno-oncology MADRID and CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE)

(NasdaqGM:AFCG), WEST PALM BEACH, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) — Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC”) today announced that it will release its financial results for the third quarter ended September 30, 2025, on Wednesday, November 12, 2025, before market open. Management will review AFC's financial results at 10:00 am ET via webcast

R1 Welcomes Estelle Barnes to Lead Enterprise Customer Engagement and Partnerships GlobeNewswire October 28, 2025 MURRAY, Utah, Oct. 28, 2025 (GLOBE NEWSWIRE) — R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the appointment of Estelle Barnes as the leader of R1's Enterprise Customer Engagement and Partnership function. In this role,

(NYSE:PFS), AUGUSTA, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) — Provident Protection Plus, a full-service insurance agency that offers comprehensive insurance programs to protect businesses, their employees, and consumers, has announced that it has retained its Best Practices status for 2025, joining an elite group of independent insurance agencies for the second time in a row

(NasdaqGM:ESPR), – Leading Cardiovascular Physician Experts to Explore Real-World Challenges and Impact on Patient Outcomes – ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced it will host a virtual key opinion leader (KOL) event for investors to discuss the clinical and real-world challenges of statin intolerance, its impact on